Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 10, 2010, Pages

  Loomba, Rohit ^a   Yang, Hwai I ^b   Su, Jun ^c   Brenner, David ^a   Iloeje, Uchenna ^c   Chen, Chien Jen ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c BRISTOL MYERS SQUIBB   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Epidemiology; Hepatocellular Carcinoma; Nutrition

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER REGISTRY; CANCER RISK; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY;

EID: 77957124872     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.06.027     Document Type: Article

References (36)

1. The global burden of disease: 2004 update. Health statistics and informatics department WHO 2008, WHO, WHO Press, Geneva, Accessed August 23, 2010. http://www.who.int/evidence/bod, S. Geneva (Ed.).
2. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745-750.
3. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003, 139:817-823.
4. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology 2009, 136:1134-1144.
5. Altekruse S.F., McGlynn K.A., Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 27:1485-1491.
6. Chen C.L., Yang H.I., Yang W.S., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008, 135:111-121.
7. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
8. Larsson S.C., Wolk A. Overweight, obesity and risk of hepatocellular carcinoma: a meta-analysis of cohort studies. Br J Cancer 2007, 97:1005-1008.
9. Kuper H., Tzonou A., Kaklamani E., et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000, 85:498-502.
10. Jee S.H., Ohrr H., Sull J.W., et al. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004, 96:1851-1856.
11. Ikeda K., Marusawa H., Osaki Y., et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med 2007, 146:649-656.
12. Yu M.W., Hsu F.C., Sheen I.S., et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997, 145:1039-1047.
13. Marrero J.A., Fontana R.J., Su G.L., et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349-1354.
14. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
15. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123:134-140.
16. Hashimoto E., Yatsuji S., Tobari M., et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009, 44(Suppl 19):89-95.
17. Loomba R., Bettencourt R., Barrett-Connor E. Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther 2009, 30:1137-1149.
18. Yang H.I., Lu S.N., Liaw Y.F., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347:168-174.
19. Chen C.J., Yang H.I., Su J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295:65-73.
20. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. WHO Expert Consultation.
21. Wang L.Y., You S.L., Lu S.N., et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003, 14:241-250.
22. Lin D.Y., Sheen I.S., Chiu C.T., et al. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 1993, 21:303-308.
23. Chen C.J., Iloeje U.H., Yang H.I. Long-term outcomes in hepatitis B: the REVEAL-HBV study. Clin Liver Dis 2007, 11:797-816. viii.
24. Rothman K.J., Greenland S., Walker A.M. Concepts of interaction. Am J Epidemiol 1980, 112:467-470.
25. Richardson D.B., Kaufman J.S. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol 2009, 169:756-760.
26. de Mutsert R., Jager K.J., Zoccali C., et al. The effect of joint exposures: examining the presence of interaction. Kidney Int 2009, 75:677-681.
27. Di Bisceglie A.M., Lyra A.C., Schwartz M., et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003, 98:2060-2063.
28. El-Serag H.B., Mason A.C. Risk factors for the rising rates of primary hepatocellular carcinoma in the United States. Arch Intern Med 2000, 160:3227-3230.
29. Donato F., Tagger A., Gelatti U., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002, 155:323-331.
30. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127:S27-S34.
31. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
32. Purohit V., Brenner D.A. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 2006, 43:872-878.
33. Siegmund S.V., Brenner D.A. Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcohol Clin Exp Res 2005, 29:102S-109S.
34. Naugler W.E., Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008, 14:109-119.
35. Sorensen H.T., Mellemkjaer L., Jepsen P., et al. Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. J Clin Gastroenterol 2003, 36:356-359.
36. Marrero J.A., Fontana R.J., Fu S., et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005, 42:218-224.